当前位置: X-MOL 学术Thorax › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection
Thorax ( IF 10 ) Pub Date : 2024-05-01 , DOI: 10.1136/thorax-2023-220370
Claire F McGroder , Mary M Salvatore , Belinda M D'Souza , Eric A Hoffman , Matthew R Baldwin , Christine Kim Garcia

We conducted a prospective single-centre cohort study of 104 multi-ethnic severe COVID-19 survivors from the first wave of the pandemic 15 months after hospitalisation. Of those who were assessed at 4 and 15 months, improvement of ground glass opacities correlated with worsened fibrotic reticulations. Despite a high prevalence of fibrotic patterns (64%), pulmonary function, grip strength, 6 min walk distance and frailty normalised. Overall, dyspnoea, cough and exhaustion did not improve and were not correlated with pulmonary function or radiographic fibrosis at 15 months, suggesting non-respiratory aetiologies. Monitoring persistent, and often subclinical, fibrotic interstitial abnormalities will be needed to determine their potential for future progression.

中文翻译:

尽管严重感染 COVID-19 后一年多仍出现持续性肺纤维化,但肺功能和运动耐量仍得到改善

我们对住院 15 个月后第一波大流行中的 104 名多种族重症 COVID-19 幸存者进行了一项前瞻性单中心队列研究。在 4 个月和 15 个月时进行评估的患者中,毛玻璃混浊的改善与纤维化网状结构的恶化相关。尽管纤维化模式的患病率很高(64%),但肺功能、握力、6 分钟步行距离和虚弱程度均正常化。总体而言,15 个月时呼吸困难、咳嗽和疲惫没有改善,并且与肺功能或放射学纤维化无关,表明非呼吸病因。需要监测持续的、通常是亚临床的纤维化间质异常,以确定其未来进展的潜力。
更新日期:2024-04-16
down
wechat
bug